193 related articles for article (PubMed ID: 22544166)
41. [Expression and significance of endothelial microparticles in children with Henoch-Schönlein purpura].
Fu SQ; Guo YJ; Song CL
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Oct; 20(10):831-834. PubMed ID: 30369358
[TBL] [Abstract][Full Text] [Related]
42. CTLA-4 exon 1 +49A/G polymorphism is associated with renal involvement in pediatric Henoch-Schönlein purpura.
Wang JJ; Shi YP; Yue H; Chun W; Zou LP
Pediatr Nephrol; 2012 Nov; 27(11):2059-2064. PubMed ID: 22700162
[TBL] [Abstract][Full Text] [Related]
43. Clinico-pathological association of Henoch-Schoenlein purpura nephritis and IgA nephropathy in children.
Mao S; Xuan X; Sha Y; Zhao S; Zhu C; Zhang A; Huang S
Int J Clin Exp Pathol; 2015; 8(3):2334-42. PubMed ID: 26045740
[TBL] [Abstract][Full Text] [Related]
44. Association of TLR4 gene polymorphisms with childhood Henoch-Schönlein purpura in a Chinese population.
Xu H; Jiang G; Shen H; Li W; Mao J; Pan Y
Rheumatol Int; 2017 Nov; 37(11):1909-1915. PubMed ID: 28905155
[TBL] [Abstract][Full Text] [Related]
45. Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy.
Li GS; Zhang H; Lv JC; Shen Y; Wang HY
Kidney Int; 2007 Mar; 71(5):448-53. PubMed ID: 17228361
[TBL] [Abstract][Full Text] [Related]
46. Lack of association between macrophage migration inhibitory factor gene promoter (-173 G/C) polymorphism and childhood Henoch-Schönlein purpura in Turkish patients.
Nalbantoglu S; Tabel Y; Mir S; Berdeli A
Cytokine; 2013 Apr; 62(1):160-4. PubMed ID: 23523092
[TBL] [Abstract][Full Text] [Related]
47. P-selectin gene -825 polymorphism is associated with risk of Henoch-Schonlein purpura nephritis.
Li J; Liu H
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S134. PubMed ID: 21385561
[No Abstract] [Full Text] [Related]
48. Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis.
Yang B; Tan X; Xiong X; Wu D; Zhang G; Wang M; Dong S; Liu W; Yang H; Li Q
Immunol Res; 2017 Jun; 65(3):592-604. PubMed ID: 27837410
[TBL] [Abstract][Full Text] [Related]
49. Lack of association between NPHS2 gene polymorphisms and Henoch-Schönlein purpura nephritis.
Zhang Y; Xudong X; Du L; Gu W; Dai Y; Liu A; Xia Y; Mao J
Arch Dermatol Res; 2007 Jun; 299(3):151-5. PubMed ID: 17393177
[TBL] [Abstract][Full Text] [Related]
50. [Relationship between leukotrienes and clinical, pathological features of Henoch-Schoenlein purpura nephritis in children].
Chen XY; Yi ZW; He QN
Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):272-5. PubMed ID: 19099729
[TBL] [Abstract][Full Text] [Related]
51. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis.
Yoshioka T; Xu YX; Yoshida H; Shiraga H; Muraki T; Ito K
Arch Dis Child; 1998 Nov; 79(5):394-9. PubMed ID: 10193250
[TBL] [Abstract][Full Text] [Related]
52. Variations of tongue coating microbiota in children with Henoch-Schönlein purpura nephritis.
Pang S; Zhao S; Bai X; Song N; Wang S; Yu J; Zhang J; Ding X
Microb Pathog; 2021 Nov; 160():105192. PubMed ID: 34534642
[TBL] [Abstract][Full Text] [Related]
53. Henoch-Schönlein purpura nephritis and IgA nephropathy: a comparative clinical study.
Calvo-Río V; Loricera J; Martín L; Ortiz-Sanjuán F; Alvarez L; González-Vela MC; González-Lamuño D; Mata C; Gortázar P; Rueda-Gotor J; Arias M; Peiró E; Martínez-Taboada VM; González-Gay MA; Blanco R
Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S45-51. PubMed ID: 23663681
[TBL] [Abstract][Full Text] [Related]
54. The pathogenesis and treatment of pediatric Henoch-Schönlein purpura nephritis.
Kawasaki Y
Clin Exp Nephrol; 2011 Oct; 15(5):648-657. PubMed ID: 21695413
[TBL] [Abstract][Full Text] [Related]
55. The efficacy and safety of immunosuppressive agents plus steroids compared with steroids alone in the treatment of Henoch-Schönlein purpura nephritis: A meta-analysis.
Tan J; Tang Y; Zhong Z; Yan S; Tan L; Tarun P; Qin W
Int Urol Nephrol; 2019 Jun; 51(6):975-985. PubMed ID: 30989564
[TBL] [Abstract][Full Text] [Related]
56. Role of p300 in the pathogenesis of Henoch-Schonlein purpura nephritis and as a new target of glucocorticoid therapy in mice.
Jiang MY; Li W; Xu XP; Zhou JQ; Jiang H
Chin Med J (Engl); 2019 Aug; 132(16):1942-1950. PubMed ID: 31365430
[TBL] [Abstract][Full Text] [Related]
57. Obesity is associated with Henoch-Schönlein Purpura Nephritis and development of end-stage renal disease in children.
Zheng X; Chen Q; Chen L
Ren Fail; 2019 Nov; 41(1):1016-1020. PubMed ID: 31735105
[No Abstract] [Full Text] [Related]
58. Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.
Delbet JD; Hogan J; Aoun B; Stoica I; Salomon R; Decramer S; Brocheriou I; Deschênes G; Ulinski T
Pediatr Nephrol; 2017 Jul; 32(7):1193-1199. PubMed ID: 28204946
[TBL] [Abstract][Full Text] [Related]
59. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
Sugiyama M; Wada Y; Kanazawa N; Tachibana S; Suzuki T; Matsumoto K; Iyoda M; Honda H; Shibata T
PLoS One; 2020; 15(4):e0232194. PubMed ID: 32324811
[TBL] [Abstract][Full Text] [Related]
60. Podocalyxin expression in renal tissues and correlation with the number of urinary podocytes in children with Henoch-Schonlein purpura nephritis.
Huang D; Wu X; Zheng W; Peng X; He X; Mo S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 37(2):161-7. PubMed ID: 22561433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
